Treatment with or without plasma exchange for patients with acquired thrombotic microangiopathy not associated with severe ADAMTS13 deficiency: a propensity score-matched study.

Li, Ang; Makar, Robert S; Hurwitz, Shelley; Uhl, Lynne; Kaufman, Richard M; Stowell, Christopher P; Dzik, Walter S; Bendapudi, Pavan K

Li, Ang; Makar, Robert S; Hurwitz, Shelley; Uhl, Lynne; Kaufman, Richard M; Stowell, Christopher P; Dzik, Walter S; Bendapudi, Pavan K.

Affiliation

Li A; Department of Medicine.
Makar RS; Harvard Medical School, Boston, Massachusetts.
Hurwitz S; Harvard Medical School, Boston, Massachusetts.
Uhl L; Blood Transfusion Service, Department of Pathology.
Kaufman RM; Harvard Medical School, Boston, Massachusetts.
Stowell CP; Center for Clinical Investigation.
Dzik WS; Harvard Medical School, Boston, Massachusetts.
Bendapudi PK; Department of Pathology, Beth Israel Deaconess Medical Center.

Transfusion ; 56(8): 2069-77, 2016 08.

Article in En | MEDLINE | ID: mdl-27232383

Subject(s)

ADAMTS13 Protein/deficiency; Plasma Exchange/methods; Thrombotic Microangiopathies/therapy; ADAMTS13 Protein/genetics; Adult; Aged; Female; Humans; Male; Middle Aged; Propensity Score; Prospective Studies; Retrospective Studies; Thrombotic Microangiopathies/genetics

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Plasma Exchange / Thrombotic Microangiopathies / ADAMTS13 Protein Type of study: Observational_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Transfusion Year: 2016 Type: Article

Fulltext

XML

PubMed Links

Search on Google